Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitor... Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. It earns the majority of its revenue from the United Kingdom. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.026 | 8.84353741497 | 0.294 | 0.3131 | 0.2907 | 96512 | 0.30133878 | CS |
| 4 | -0.0291 | -8.33572042395 | 0.3491 | 0.395 | 0.2907 | 332329 | 0.34049464 | CS |
| 12 | -0.0099 | -3.00090936647 | 0.3299 | 0.89 | 0.2907 | 2554984 | 0.44324449 | CS |
| 26 | -0.67 | -67.6767676768 | 0.99 | 2.49 | 0.2907 | 1958961 | 0.64524086 | CS |
| 52 | -1.96 | -85.9649122807 | 2.28 | 4 | 0.2907 | 1202602 | 0.95204293 | CS |
| 156 | -47.23 | -99.3270241851 | 47.55 | 50.7 | 0.2907 | 572018 | 6.0276345 | CS |
| 260 | -128.68 | -99.7519379845 | 129 | 288.75 | 0.2907 | 480755 | 31.20145869 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
